Lv52
1590 积分 2023-11-10 加入
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials
1天前
已完结
Targeting OX40: rocatinlimab—a novel therapy for atopic dermatitis
1天前
已完结
Fibroblast heterogeneity in 2025
5天前
已完结
A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation
14天前
已完结
Origin, development and therapy of colorectal cancer from the perspective of a biologist and an oncologist
20天前
已关闭
Testing for Off-target Binding
27天前
已完结
Research progress in OX40/OX40L in allergic diseases
1个月前
已完结
The anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II Fc receptors
1个月前
已完结
Systemic sclerosis in adults. Part I: Clinical features and pathogenesis
2个月前
已完结
IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease
2个月前
已完结
皖公网安备34019202002308
